WASHINGTON U.S. House leaders have decided against holding a vote on a reworked healthcare system overhaul this week after failing to find the necessary support, congressional aides said on Thursday. | Video
- Home blood pressure monitors may not be accurate enough
- With Obamacare in doubt, California asks insurers to double up on rate filings
- U.S. FDA approves Takeda's lung cancer drug as second-line treatment
- Malaria, wiped out in U.S., still plagues American travelers
- U.S. FDA approves Novartis' leukemia treatment
MEXICO CITY Mexico's Lower House of Congress passed a bill on Friday to legalize the use of marijuana and cannabis for medical and scientific needs, a step closer to outright legalization in a country long scarred by warring drug cartels.
The U.S. Food and Drug Administration on Friday approved Radius Health Inc's drug to treat osteoporosis in postmenopausal women at high risk of fracture or those who have failed other therapies.
(Reuters Health) - Having a family history of prostate cancer doesn’t make it more risky for men with a new diagnosis of the disease to initially hold off on active treatment in favor of monitoring with periodic lab tests, a research review suggests.
(Reuters Health) - Instead of eating less saturated fat and worrying about so-called bad cholesterol, a group of doctors suggests an alternative approach for preventing heart disease.